文献速递临床试验与 GCP流行病学与生物统计

严重空气污染下哮喘患者的救援干预策略:单中心前瞻性随机对照试验方案

The rescue intervention strategy for asthma patients under severe air pollution: a protocol for a single-centre prospective randomized controlled trial.
PubMed 文献 · Trials · 2020-11-04

干预组在严重污染期间(AQI<200)在原治疗基础上加用布地奈德/福莫特罗,对照组维持原治疗,随访1年,主要结局为每年哮喘急性发作频率。

要点

  • 严重空气污染期间加用布地奈德/福莫特罗可能降低哮喘急性发作风险
  • 主要结局为每年哮喘急性发作频率,随访1年
  • 试验为单中心、前瞻性、随机、标准治疗平行对照设计

核心结论

  • 该试验结果旨在为严重空气污染期间降低哮喘急性发作风险提供新的临床策略。

关键数值与推荐

  • 救援干预策略组在原治疗基础上加用布地奈德/福莫特罗(160 μg/4.5 μg/剂,1-2剂/次,每日两次),直至严重污染结束(AQI<200)。
  • 原治疗包括未使用吸入药物、按需使用短效β2受体激动剂(SABA)或使用布地奈德/福莫特罗(160 μg/4.5 μg/剂,1-2剂/次,每日两次)。
  • 主要结局为每年哮喘急性发作频率;次要结局包括每人每年非计划门诊就诊、急诊就诊、住院、医疗费用及哮喘急性发作所致死亡的平均数。
  • 随访观察期为1年。

临床怎么用

  • 在严重空气污染(AQI<200)期间,对非急性发作期哮喘患者可考虑在原治疗基础上加用布地奈德/福莫特罗作为救援干预。

局限性

  • 单中心设计可能限制结果外推性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Asthma is a common chronic airway inflammatory disease. Exacerbations of asthma not only accelerate the progression of the disease but also increase the incidence of hospitalization and death. Studies have shown that air pollution is a high-risk factor for asthma exacerbations. However, few treatment strategies have been recommended to reduce the risk of severe air pollution-related asthma exacerbations. METHODS/DESIGN: This is a single-centre, prospective, randomized and standard treatment parallel control clinical trial. Seventy-two asthma patients in the nonexacerbation stage according to GINA guidelines 2017 will be recruited and randomized into the rescue intervention strategy (RIS) group and control group. Original treatments for the participants will include no use of inhaled medicine, the use of short-acting β-agonists (SABA) on demand or the use of budesonide/formoterol (160 μg/4.5 μg/dose, 1-2 dose/time, b.i.d.). The rescue intervention strategy for the RIS group will be budesonide/formoterol plus the original treatment until the severe pollution ends (air quality index, AQI < 200). The control group will maintain the original treatment. The follow-up observation period will last 1 year. The primary outcome is the frequency of asthma exacerbations per year. Secondary outcomes include the mean number of unplanned outpatient visits, emergency visits, hospitalizations, medical costs and mortality caused by asthma exacerbations per patient per year. DISCUSSION: The results of this trial will provide a novel strategy to guide clinical practice in decreasing the risk of asthma exacerbations under severe air pollution. TRIAL REGISTRATION: ChiCTR ChiCTR1900026757 . Registered on 20 October 2019-retrospectively registered.

来源:Trials,查看原文。版权归原作者所有。

引用

  1. Yang X, Huang J, Hu Y, et al. The rescue intervention strategy for asthma patients under severe air pollution: a protocol for a single-centre prospective randomized controlled trial. Trials. 2020. PMID: 33148308. doi:10.1186/s13063-020-04830-0

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。